
Corteva sues startup rival Inari for patent infringement
The lawsuit seeks to prevent Inari “from continuing its brazen efforts to steal Corteva’s groundbreaking, patent-protected work,” according to the complaint.
The lawsuit seeks to prevent Inari “from continuing its brazen efforts to steal Corteva’s groundbreaking, patent-protected work,” according to the complaint.
A Noblesville ordinance’s language for sign relocation was ambiguous with its usage of “relocate” and “move,” the Indiana Supreme Court affirmed Monday.
If not successfully appealed, the order would strip Trump of his authority to make strategic and financial decisions over some of his key properties.
Indiana election law’s silence on corporate contributions to independent-expenditure political action committees means such contributions are prohibited or otherwise limited, a split Indiana Supreme Court has ruled.
The court declined to apply the state’s new statute, but found that Lutheran’s physician noncompete agreement was unenforceable, overbroad and unreasonable.
Frank Emmert of the IU McKinney School of Law talks about how the legal and ethical questions that will arise from the increasing use of artificial intelligence could test current laws and courts’ ability to untangle the technology.
Legal counsel for Duke Energy argued two cases before the Indiana Supreme Court Thursday—from both sides of the courtroom—on separate matters relating to where it maintains its equipment and facilities.
Appearing in the biggest antitrust trial in a quarter century, DuckDuckGo founder Gabriel Weinberg testified Thursday that it was hard for his small search engine company to compete with Google.
Lilly is suing medical spas, wellness centers and compounding pharmacies in various U.S. states that sell unapproved versions of its blockbuster diabetes drug, which is frequently used off-label for weight loss.
Steve Buyer was convicted in connection with insider trading involving the $26.5 billion merger of T-Mobile and Sprint, announced in April 2018, and illegal trades in the management consulting company Navigant.
The Indiana Supreme Court Disciplinary Commission filed a three-count disciplinary complaint against Indiana Attorney General Todd Rokita for comments he made about his investigation into Dr. Caitlin Bernard.
Attorney General Todd Rokita has filed a lawsuit alleging IU Health failed to report, review and enforce privacy standards in connection with Dr. Caitlin Bernard talking publicly about an abortion she performed on a 10-year-old.
President Joe Biden’s son has also been under investigation for his business dealings. The special counsel has indicated that charges of failure to pay taxes on time could be filed in Washington or in California, where he lives.
North Dakota-based restaurant company BT Brands, which dropped its lawsuit against Noble Roman’s late last week, said it will continue in its efforts to effect changes to the Noble Roman’s board of directors.
Over the next 10 weeks, the Justice Department and a group of state attorneys general will argue that Google has illegally abused its monopoly power to run roughshod over rivals, inking deals to ensure dominance.
Thursday’s hearing dealt with whether Indiana’s election code prohibits or limits corporate contributions to political action committees that engage in independent campaign-related expenditures.
Thousands of Black, Latino and other minority business owners are scrambling to prove that their race puts them at a “social disadvantage” after a federal judge declared a key provision of a popular Small Business Administration program unconstitutional.
Since the U.S. Supreme Court cleared the way for legalized sports betting five years ago, nearly three-fourths of the states have moved swiftly to allow it.
The U.S. government is taking a big step toward forcing a defiant Tennessee company to recall 52 million air bag inflators that could explode, hurl shrapnel and injure or kill people.
The measure has the potential to help struggling cannabis companies in states where marijuana is legal and could remove barriers to scientific research into the health benefits of the drug.